BackVertex Pharmaceuticals Overview

Vertex Pharmaceuticals Accounts Payable

Track Vertex Pharmaceuticals's accounts payable ($490M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$489.30M

Peer average

Loading

Vertex Pharmaceuticals Accounts Payable History

Loading

Vertex Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Vertex Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vertex Pharmaceuticals (VRTX) FAQ

As of the most recent data (March 2026), VRTX shows a accounts payable of $490M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRTX's accounts payable is now $490M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Vertex Pharmaceuticals is outperforming or lagging.

Tracking VRTX's accounts payable over time shows whether Vertex Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $490M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Vertex Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $490M) with ownership activity and broader fundamentals.

Vertex Pharmaceuticals's accounts payable is $490M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.